GOG Foundation
J

New Frontiers of PARPi Therapy in Pancreatic and Biliary Cancers: Tumor Profiling, Chemo for DDR-Defective Tumors, Mechanisms of PARPi Resistance

By GOG Foundation FEATURING James Abbruzzese
By GOG Foundation FEATURING James Abbruzzese
424 views
January 22, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Recommended

12:50

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxe…

2024 ASCO® Annual Meeting Insights Hub

E. Dotan

718 views

·

5 months ago
27:37

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

ASCO GI 2023 Conference Coverage

N. Uboha, A. Turk, K. Spencer, M. Cecchini

4.1K views

·

1 year ago
23:58

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

3.1K views

·

1 year ago
20:07

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials Includ…

Insights from 2023 ASCO® Annual Meeting

Y. Janjigian, S. Cytryn, S. Maron

1.6K views

·

1 year ago
22:19

ESMO 2024 Summary: Latest Advances in Targeted Therapies for Pancrea…

2024 ESMO Annual Meeting Insights Hub

D. Melisi

223 views

·

1 month ago
06:47

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

2.1K views

·

1 year ago
17:05

ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinical Ut…

2024 ASCO® Annual Meeting Insights Hub

S. Cohen

348 views

·

5 months ago
17:02

Targeting KRAS in Pancreatic Cancer

Harshabad Singh

314 views

·

5 months ago
06:03

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Total Health

A. Grothey

246 views

·

8 months ago
04:25

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX v…

ecancer

J. Knox

196 views

·

5 months ago
12:27

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreatic Ad…

2024 ASCO® Annual Meeting Insights Hub

J. Knox

164 views

·

4 months ago
12:08

GI Oncology Year in Review: Precision Medicine Update in Metastatic …

Yale Cancer Center

J. Lacy

237 views

·

8 months ago
03:50

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

UCLA Health

Z. Wainberg

286 views

·

8 months ago
07:37

ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pembro i…

2024 ASCO® Annual Meeting Insights Hub

B. Weinberg

195 views

·

5 months ago
21:03

Clinical Takeaways in From Recent Key Trials in Pancreatic Cancer

Hani Babiker

130 views

·

2 months ago
10:53

GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …

Yale Cancer Center

J. Lacy

207 views

·

8 months ago
37:16

The TAPUR Study: Evaluating Targeted Therapies Based on Genetic Alte…

University of Miami Sylvester Comprehensive Cancer Center

R. Schilsky

138 views

·

2 months ago
07:53

Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia

Total Health

D. Lin

296 views

·

1 year ago
25:02

ESMO GI 2024 Insights: Role of Personalized Medicine in Pancreatic C…

Insights from 2024 ESMO GI Annual Meeting

T. Seufferlein

125 views

·

4 months ago
06:28

FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…

Shubham Pant

199 views

·

8 months ago
AUTOPLAY